SUBSTANCE Trademark

Trademark Overview

On Monday, July 1, 2024, a trademark application was filed for SUBSTANCE with the United States Patent and Trademark Office. The USPTO has given the SUBSTANCE trademark a serial number of 98978413. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Thursday, June 11, 2026. This trademark is owned by SPINEART S.A.. The SUBSTANCE trademark is filed in the Pharmaceutical Products category with the following description:

Biodegradable implants comprising living tissue for use in guided tissue regeneration; surgical implants comprised of living tissues; biological tissue grafts for implantation; biological implants comprising living tissue
substance

General Information

Serial Number98978413
Word MarkSUBSTANCE
Filing DateMonday, July 1, 2024
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateThursday, June 11, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 15, 2025

Trademark Statements

Goods and ServicesBiodegradable implants comprising living tissue for use in guided tissue regeneration; surgical implants comprised of living tissues; biological tissue grafts for implantation; biological implants comprising living tissue

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 1, 2024
Primary Code005
First Use Anywhere DateTuesday, December 31, 2024
First Use In Commerce DateTuesday, December 31, 2024

Trademark Owner History

Party NameSPINEART S.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressPlan-les-Ouates CH-1228
CH
Party NameSPINEART S.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressPlan-les-Ouates CH-1228
CH

Trademark Events

Event DateEvent Description
Monday, July 1, 2024NEW APPLICATION ENTERED
Monday, July 1, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 27, 2024ASSIGNED TO EXAMINER
Monday, December 30, 2024NON-FINAL ACTION WRITTEN
Monday, December 30, 2024NON-FINAL ACTION E-MAILED
Monday, December 30, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 7, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 7, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 7, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 18, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 9, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 15, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 15, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 10, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, December 8, 2025SOU TEAS EXTENSION RECEIVED
Monday, December 8, 2025TEAS STATEMENT OF USE RECEIVED
Monday, December 8, 2025TEAS REQUEST TO DIVIDE RECEIVED
Monday, December 8, 2025SOU EXTENSION 1 FILED
Friday, June 5, 2026SOU EXTENSION 1 GRANTED
Friday, June 5, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, June 6, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 5, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 5, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 5, 2026TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, June 5, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 10, 2026SOU TEAS EXTENSION RECEIVED
Monday, December 8, 2025DIVISIONAL REQUEST RECEIVED
Thursday, June 11, 2026DIVISIONAL PROCESSING COMPLETE
Thursday, June 11, 2026ITU LETTER MAILED, NO RESPONSE REQUIRED
Monday, December 8, 2025USE AMENDMENT FILED
Thursday, June 11, 2026STATEMENT OF USE PROCESSING COMPLETE

Related Keywords

substance tissue living implants biological comprising grafts implantation tissues regeneration guided